Literature DB >> 3199842

Use of the MTT assay for rapid determination of chemosensitivity of human leukemic blast cells.

B G Campling1, J Pym, P R Galbraith, S P Cole.   

Abstract

A microcytotoxicity assay employing a tetrazolium salt has been adapted for testing the response of human leukemic blast cells to a variety of chemotherapeutic agents. After exposure to various concentrations of drugs, the viability of fresh leukemic blast cells was measured using a tetrazolium salt, MTT, which is converted to blue formazan crystals by living cells. The amount of formazan produced was quantitated using a microtitre plate spectrophotometer. In the present study, optimal conditions for chemosensitivity testing of human leukemia samples were determined, and the relative chemosensitivity of five patient samples was tested.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3199842     DOI: 10.1016/0145-2126(88)90036-7

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  25 in total

1.  Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier.

Authors:  Okhil K Nag; Jawad Naciri; Eunkeu Oh; Christopher M Spillmann; James B Delehanty
Journal:  J Vis Exp       Date:  2017-02-08       Impact factor: 1.355

2.  Antiviral activity of recombinant cyanovirin-N against HSV-1.

Authors:  Hong Yu; Zong-tao Liu; Rui Lv; Wen-qing Zhang
Journal:  Virol Sin       Date:  2010-12-21       Impact factor: 4.327

3.  Nonylphenolethoxylates as malarial chloroquine resistance reversal agents.

Authors:  I Crandall; J Charuk; K C Kain
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

4.  Cholesterol and phytosterols differentially regulate the expression of caveolin 1 and a downstream prostate cell growth-suppressor gene.

Authors:  Godwin O Ifere; Anita Equan; Kereen Gordon; Peri Nagappan; Joseph U Igietseme; Godwin A Ananaba
Journal:  Cancer Epidemiol       Date:  2010-05-12       Impact factor: 2.984

5.  Anti-leukemic effect of 2-pyrone derivatives via MAPK and PI3 kinase pathways.

Authors:  Jin Sun Yoon; Young Woong Won; Seo Ju Kim; Suk Joong Oh; Eun Shil Kim; Byoung Kook Kim; Cheon Gyu Cho; Jung Hye Choi; Byeong Bae Park; Min Ho Lee; Young Yiul Lee
Journal:  Invest New Drugs       Date:  2012-04-19       Impact factor: 3.850

6.  Effects of microenvironment on morphology and function of the microglial cell line BV-2.

Authors:  M A Laurenzi; C Arcuri; R Rossi; P Marconi; V Bocchini
Journal:  Neurochem Res       Date:  2001-11       Impact factor: 3.996

7.  Casein kinase 2α regulates multidrug resistance-associated protein 1 function via phosphorylation of Thr249.

Authors:  Elzbieta I Stolarczyk; Cassandra J Reiling; Kerry A Pickin; Ryan Coppage; Marc R Knecht; Christian M Paumi
Journal:  Mol Pharmacol       Date:  2012-06-13       Impact factor: 4.436

8.  Human cytomegalovirus UL76 encodes a novel virion-associated protein that is able to inhibit viral replication.

Authors:  Shang-Kwei Wang; Chang-Yih Duh; Cheng-Wen Wu
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS 126 in models of triple-negative breast cancer.

Authors:  Jens C Hahne; Heike Schmidt; Susanne R Meyer; Jörg B Engel; Johannes Dietl; Arnd Honig
Journal:  J Cancer Res Clin Oncol       Date:  2013-02-26       Impact factor: 4.553

10.  Methotrexate cytotoxicity determination using the MTT assay following enzymatic depletion of thymidine and hypoxanthine.

Authors:  M Haber; J Madafiglio; M D Norris
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.